Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exploring Cortical Remyelination in Children With Multiple Sclerosis — Stella

Home/Children With Multiple Sclerosis/Exploring Cortical Remyelination in Children With Multiple Sclerosis

View on ClinicalTrials.gov

Recruiting

Back to Children With Multiple Sclerosis trials

Exploring Cortical Remyelination in Children With Multiple Sclerosis

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

France

Service de Neurologie Pédiatrique, Hôpital du Kremlin Bicêtre, Le Kremlin-Bicêtre

CIC Neurosciences - Pitié Salpêtrière, Paris

Service de Neurologie, GH Pitié Salpêtrière, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~40 participants

Started

August 2022

Primary completion

September 2026

Age range

12 Years – 18 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.